Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE 0005659700) and IBt s.a. have reached an agreement about the consolidation of their respective Businesses for Prostate Cancer Implants and executed a Share Contribution Agreement, in which Eckert & Ziegler sells its Implant Business to IBt with immediate effect in exchange for 6.75 million IBt shares. As a result, Eckert & Ziegler will become IBt s largest shareholder, owning about 40% of all rights to dividends and other economic benefits, and close to 30% of the voting rights in IBt s shareholder meeting. The difference in the two ratios is due to the existence of so-called Beneficiary Shares, which only convey voting rights in the shareholder meeting, but not to dividends.
Further details are provided in a press release which is available on the company s homepage.
Further details are provided in a press release which is available on the company s homepage.
